BeOne Medicines
ONC
#542
Rank
S$59.56 B
Marketcap
S$521.45
Share price
5.09%
Change (1 day)
21.73%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2023 (TTM): S-$22.82

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is S$7.66. In 2022 the company made an earnings per share (EPS) of S-$24.82 a decrease over its 2021 EPS that were of S-$19.49.

EPS history for BeOne Medicines from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$22.82-8.06%
2022S-$24.8227.35%
2021S-$19.49-19.96%
2020S-$24.3520.81%
2019S-$20.1631.52%
2018S-$15.32417.57%
2017S-$2.96-37.16%
2016S-$4.71158.95%
2015S-$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.12-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.22-115.89%๐Ÿ‡บ๐Ÿ‡ธ USA